Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urinary Tract Infection Risk in Women With Asymptomatic Bacteriuria or Urinalysis Abnormality at the Initiation of SGLT2 Inhibitors

NCT05520684 is registered in ClinicalTrials.gov with Trabzon Arakli Bayram Halil Public Hospital as lead sponsor.

NCT NCT05520684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05520684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urinary Tract Infection Risk in Women With Asymptomatic Bacteriuria or Urinalysis Abnormality at the Initiation of SGLT2 Inhibitors
Lead sponsor
Trabzon Arakli Bayram Halil Public Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 15, 2022
Completion date
January 1, 2023
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type2diabetes, sglt2 inhibitor, urinary tract infection